Colgate-Palmolive Company (CL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,266,000 | 1,499,000 | 726,000 | 3,049,000 | 2,270,000 |
| Depreciation Amortization | 457,000 | 299,000 | 148,000 | 605,000 | 457,000 |
| Income taxes - deferred | 8,000 | -17,000 | -24,000 | -77,000 | -98,000 |
| Accounts receivable | -180,000 | -152,000 | -174,000 | -56,000 | -184,000 |
| Other Working Capital | -163,000 | -404,000 | -331,000 | 344,000 | 47,000 |
| Other Operating Activity | 357,000 | 259,000 | 255,000 | 242,000 | 346,000 |
| Operating Cash Flow | $2,745,000 | $1,484,000 | $600,000 | $4,107,000 | $2,838,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -29,000 | -34,000 | -37,000 | -10,000 | -98,000 |
| PPE Investments | -387,000 | -232,000 | -124,000 | -561,000 | -377,000 |
| Net Acquisitions | -293,000 | -293,000 | N/A | N/A | N/A |
| Other Investing Activity | -5,000 | -1,000 | 2,000 | 37,000 | 21,000 |
| Investing Cash Flow | $-714,000 | $-560,000 | $-159,000 | $-534,000 | $-454,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 139,000 | -30,000 | 164,000 | 93,000 | 337,000 |
| Debt Issued | 497,000 | 497,000 | N/A | 2,000 | 2,000 |
| Debt Repayment | -655,000 | -139,000 | -4,000 | -503,000 | -502,000 |
| Common Stock Issued | 83,000 | 65,000 | 40,000 | 638,000 | 611,000 |
| Common Stock Repurchased | -804,000 | -516,000 | -284,000 | -1,739,000 | -1,284,000 |
| Dividend Paid | -1,300,000 | -880,000 | -406,000 | -1,789,000 | -1,275,000 |
| Other Financing Activity | 145,000 | 136,000 | 32,000 | -91,000 | 1,000 |
| Financing Cash Flow | $-1,895,000 | $-867,000 | $-458,000 | $-3,389,000 | $-2,110,000 |
| Exchange Rate Effect | 47,000 | 62,000 | 33,000 | -54,000 | -6,000 |
| Beginning Cash Position | 1,096,000 | 1,096,000 | 1,096,000 | 966,000 | 966,000 |
| End Cash Position | 1,279,000 | 1,215,000 | 1,112,000 | 1,096,000 | 1,234,000 |
| Net Cash Flow | $183,000 | $119,000 | $16,000 | $130,000 | $268,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,745,000 | 1,484,000 | 600,000 | 4,107,000 | 2,838,000 |
| Capital Expenditure | -387,000 | -232,000 | -124,000 | -561,000 | -377,000 |
| Free Cash Flow | 2,358,000 | 1,252,000 | 476,000 | 3,546,000 | 2,461,000 |